It is encouraging to see the level of current investment and its breadth. With the continuing rise of antimicrobial resistance and implications cutting across all areas of medicine, investments are a necessary foundation for urgently needed progress. The Dynamic Dashboard will help funders in their future funding decisions. Some high-level summary of information from the Dynamic Dashboard can be found here.
24.01.2026
New Strategic Partnership with the Chinese Academy of Sciences
Global AMR R&D Hub and Chinese Academy of Sciences launch strategic partnership to advance antimicrobial resistance research.
